| Frequency of TERT promoter mutations in human cancers J Vinagre, A Almeida, H Pópulo, R Batista, J Lyra, V Pinto, R Coelho, ... Nature communications 4 (1), 2185, 2013 | 994 | 2013 |
| TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas M Melo, AG da Rocha, J Vinagre, R Batista, J Peixoto, C Tavares, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E754-E765, 2014 | 599 | 2014 |
| TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation H Pópulo, P Boaventura, J Vinagre, R Batista, A Mendes, R Caldas, ... Journal of Investigative Dermatology 134 (8), 2251-2257, 2014 | 145 | 2014 |
| TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease M Melo, A Gaspar da Rocha, R Batista, J Vinagre, MJ Martins, G Costa, ... The Journal of Clinical Endocrinology & Metabolism 102 (6), 1898-1907, 2017 | 136 | 2017 |
| Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review R Batista, N Vinagre, S Meireles, J Vinagre, H Prazeres, R Leão, ... Diagnostics 10 (1), 39, 2020 | 106 | 2020 |
| NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features C Tavares, MJ Coelho, C Eloy, M Melo, AG da Rocha, A Pestana, ... Endocrine connections 7 (1), 78-90, 2018 | 80 | 2018 |
| The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism R Batista, A Cruvinel‐Carloni, J Vinagre, J Peixoto, TA Catarino, ... International journal of cancer 139 (2), 414-423, 2016 | 70 | 2016 |
| Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study R Batista, J Vinagre, H Prazeres, C Sampaio, P Peralta, P Conceição, ... Frontiers in genetics 10, 1237, 2019 | 60 | 2019 |
| TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma MA Campos, S Macedo, M Fernandes, A Pestana, J Pardal, R Batista, ... Journal of the American Academy of Dermatology 80 (3), 660-669. e6, 2019 | 40 | 2019 |
| mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression C Tavares, C Eloy, M Melo, A Gaspar da Rocha, A Pestana, R Batista, ... International journal of molecular sciences 19 (5), 1448, 2018 | 39 | 2018 |
| mTOR activation in medullary thyroid carcinoma with RAS mutation J Lyra, J Vinagre, R Batista, V Pinto, H Prazeres, F Rodrigues, C Eloy, ... European journal of endocrinology 171 (5), 633-640, 2014 | 39 | 2014 |
| Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior LB Ferreira, C Tavares, A Pestana, CL Pereira, C Eloy, MT Pinto, P Castro, ... Oncotarget 7 (32), 52003, 2016 | 35 | 2016 |
| Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients CA Sieverink, RPM Batista, HJM Prazeres, J Vinagre, C Sampaio, ... Diagnostics 10 (10), 745, 2020 | 30 | 2020 |
| Genetic determinants for prediction of outcome of patients with papillary thyroid carcinoma AA Póvoa, E Teixeira, MR Bella-Cueto, R Batista, A Pestana, M Melo, ... Cancers 13 (9), 2048, 2021 | 28 | 2021 |
| Multinodular goiter progression toward malignancy in a case of DICER1 syndrome: histologic and molecular alterations I Gullo, R Batista, P Rodrigues-Pereira, P Soares, H Barroca, ... American journal of clinical pathology 149 (5), 379-386, 2018 | 28 | 2018 |
| Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas P Boaventura, D Pereira, A Mendes, R Batista, AF da Silva, I Guimaraes, ... Journal of Dermatological Science 73 (1), 31-39, 2014 | 27 | 2014 |
| TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients R Batista, L Lima, J Vinagre, V Pinto, J Lyra, V Máximo, L Santos, ... International journal of molecular sciences 21 (3), 947, 2020 | 22 | 2020 |
| Inhibitory effects of antagonists of growth hormone-releasing hormone (GHRH) in thyroid cancer H Pópulo, B Nunes, C Sampaio, R Batista, MT Pinto, TB Gaspar, ... Hormones and Cancer 8, 314-324, 2017 | 19 | 2017 |
| Loss of mitochondrial SDHB expression: what is its role in diffuse thyroid lipomatosis? E Lau, P Freitas, J Costa, R Batista, V Máximo, R Coelho, L Matos-Lima, ... Hormone and Metabolic Research 47 (03), 165-167, 2015 | 19 | 2015 |
| Prognostic significance of RAS mutations and P53 expression in cutaneous squamous cell carcinomas MA Campos, S Macedo, MS Fernandes, A Pestana, J Pardal, R Batista, ... Genes 11 (7), 751, 2020 | 18 | 2020 |
Joao VinagreInstitute of Pathology and Molecular Imunology of the University of Porto在 ipatimup.pt 的电子邮件经过验证
